...
首页> 外文期刊>The Breast : >Ultrasound-guided vacuum assisted breast biopsy in the assessment of C3 breast lesions by ultrasound-guided fine needle aspiration cytology: results and costs in comparison with surgery.
【24h】

Ultrasound-guided vacuum assisted breast biopsy in the assessment of C3 breast lesions by ultrasound-guided fine needle aspiration cytology: results and costs in comparison with surgery.

机译:超声引导下的真空辅助乳腺活检通过超声引导下的细针穿刺细胞学评估C3乳腺病变:与手术相比的结果和成本。

获取原文
获取原文并翻译 | 示例
           

摘要

Breast lesions defined C3 at ultrasound (US)-guided fine needle aspiration cytology (FNAC) are probably benign, but exhibit atypias. We evaluate the results of US-guided vacuum assisted breast biopsy (VABB) of these lesions. Patients diagnosed C3 by US-FNAC, submitted to US-VABB and with a minimum follow-up of 36 months or surgery were enrolled. Cost outcome of this diagnostic protocol was evaluated. We evaluated 138 patients with non-palpable C3 lesions. In 2/138 (1.4%) cases VABB results were inadequate. VABB diagnosed: 17/138 (12.3%) malignant and 119/138 (86.2%) benign lesions. In 28/138 cases (20.3%) surgery retrieved 18/28 (64.3%) malignant lesions. One false negative result of VABB was observed. Sensitivity and specificity of VABB resulted 94.4% and 100%. Our diagnostic algorithm estimated a 45% mean decrease of costs using VABB when compared with surgical biopsy of all C3 lesions.
机译:在超声(美国)引导下的细针穿刺细胞学检查(FNAC)中定义为C3的乳腺病变可能是良性的,但表现为非典型性。我们评估这些病变的美国引导下的真空辅助乳房活检(VABB)的结果。由US-FNAC诊断为C3,已接受US-VABB且至少随访36个月或接受手术的患者入选。评估了该诊断方案的成本结果。我们评估了138例无法触及的C3病变的患者。在2/138(1.4%)例中,VABB结果不足。 VABB诊断为:17/138(12.3%)恶性和119/138(86.2%)良性病变。在28/138例(20.3%)的手术中,发现18/28(64.3%)的恶性病变。观察到VABB的一项假阴性结果。 VABB的敏感性和特异性分别为94.4%和100%。我们的诊断算法估计,与所有C3病变的手术活检相比,使用VABB可使费用平均减少45%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号